Author

Veronica H. Jude

Observed names: V. Jude, Veronica Jude

Institution: Bristol-Myers Squibb (United States)

Observed institutions: Baylor College of Medicine, Riley Hospital for Children, Bristol-Myers Squibb (United States), Children's Hospital of San Antonio, Methodist Children’s Hospital, Indiana University School of Medicine

OpenAlex ID: A5083397787

High White Blood Cell Concentration in the Peripheral Blood Stem Cell Product Can Induce Seizures during Infusion of Autologous Peripheral Blood Stem Cells

2011 · Carlos Bachier, Josh Potter, et al. · Transplantation and Cellular Therapy · 20

Recent Advances in Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia

2010 · Veronica Jude, Ka Wah Chan · Current Hematologic Malignancy Reports · 5

Clinical Practice Implications of Immunizations After Pediatric Bone Marrow Transplant

2012 · Julie L. Luke, Lisa McDonald, et al. · Journal of Pediatric Oncology Nursing · 3

Medication Errors Among Pediatric Hematopoietic Stem Cell Transplant Recipients in an Outpatient Clinic

2012 · L.R. McDonald, J. Luke, et al. · Transplantation and Cellular Therapy · 3

Development of an Evidence-Based Clinical Guideline for Age-Appropriate Screening, Prevention, and Management of Bone Abnormalities in Children Post–Hematopoietic Stem Cell Transplant

2013 · Lisa McDonald, Julie Luke, et al. · Journal of Pediatric Oncology Nursing · 2

Outcomes in Patients (pts) with R/R Large B-Cell Lymphoma (LBCL) Who Received Nonconforming Product (NCP) to Commercial Release of Lisocabtagene Maraleucel (liso-cel) in the United States (US)

2024 · Paolo Caimi, Stephen J. Schuster, et al. · Transplantation and Cellular Therapy · 1

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Outcomes for Juvenile Myelomonocytic Leukemia (JMML), a 15-Year Single Center Experience

2014 · Troy C. Quigg, Lisa McDonald, et al. · Transplantation and Cellular Therapy · 1

Development of a Pediatric HSCT Multi-Disciplinary Survivor Clinic

2013 · Lisa McDonald, Julie Luke, et al. · Transplantation and Cellular Therapy · 1

237: Unrelated Donor Cord Blood Stem Cell Transplantation for Leukocyte Adhesion Deficiency (LAD)

2008 · K.A. Robertson, W.S. Goebel, et al. · Transplantation and Cellular Therapy · 1

Patients (pts) with R/R large B-cell lymphoma (LBCL) treated with lisocabtagene maraleucel (liso-cel) nonconforming product (NCP) under the Expanded Access Protocol (EAP).

2024 · Brian G. Till, Caron Alyce Jacobson, et al. · Journal of Clinical Oncology

Development of a Multidisciplinary Nutritional Support Team in a New Pediatric Bone Marrow Transplant Program

2018 · Lisa McDonald, Veronica H. Jude, et al. · Transplantation and Cellular Therapy

Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation

2013 · Behyar Zoghi, Paul J. Shaughnessy, et al. · Transplantation and Cellular Therapy

Ethnicity Between Donor and Recipient Affects Overall Survival in Umbilical Cord Blood Transplantation

2012 · C. Bachier, P.S. Cheruku, et al. · Transplantation and Cellular Therapy

Seizures During Infusion of Autologous Peripheral Blood Stem Cells Are Related to High White Blood Cell Concentration in the Peripheral Blood Stem Cell Product and Can Be Prevented by Dilution of Product with Autologous Plasma

2011 · Carlos Bachier, Grant Potter, et al. · Blood

Mismatches in Ethnicity Between Donor and Recipient Affects Overall Survival In Umbilical Cord Blood Transplantation,

2011 · Patali Shikhi Cheruku, Veronica H. Jude, et al. · Blood

Reduced Intensity Conditioning (RIC) Regimen of Alemtuzmab (A), Fludarabine (F), and Melphalan (M) for Transplantation of Pediatric Non-Malignant Hematologic Disorders (NMHD): Outcome Affected by Stem Cell Source.

2010 · Ka Wah Chan, Michael Grimley, et al. · Blood

Works count: 16

Citation count: 37

H-index: 3

I10-index: 1